NASDAQ: PBYI
Puma Biotechnology Inc Stock Ownership - Who owns Puma Biotechnology?

Insider buying vs selling

Have Puma Biotechnology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael Patrick MillerDirector2026-11-1115,000$8.10
$121.46kSell
Troy Edward WilsonDirector2026-09-145,000$9.10
$45.50kSell
Alessandra CesanoDirector2026-09-1450,000$2.93
$146.50kBuy
Alessandra CesanoDirector2026-09-1462,150$9.12
$566.99kSell
Maximo F. NouguesChief Financial Officer2026-07-069,386$8.26
$77.56kSell
Douglas M. HuntOfficer2026-07-068,460$8.26
$69.90kSell
Alan H. AuerbachPresident and CEO2026-07-0644,058$8.26
$364.05kSell
Brian M. StuglikDirector2026-06-128,100$7.20
$58.31kSell
Troy Edward WilsonDirector2026-06-1210,800$7.20
$77.75kSell
Jay M. MoyesDirector2026-06-1222,000$7.22
$158.80kSell

1 of 2

PBYI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PBYI insiders and whales buy or sell their stock.

PBYI Shareholders

What type of owners hold Puma Biotechnology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Adage Capital Partners GP LLC17.17%8,879,139$63.22MInsider
Alan H. Auerbach14.05%7,261,671$51.70MInsider
Adage Capital Partners LP6.19%3,200,000$22.78MInsider
Frank Zavrl1.86%960,069$6.84MInsider
Maximo F. Nougues0.45%230,637$1.64MInsider
Douglas M. Hunt0.38%196,841$1.40MInsider
Jeffrey Jerome Ludwig0.30%156,792$1.12MInsider
Thomas Malley0.30%156,551$1.11MInsider
Alvin F. Wong0.27%141,241$1.01MInsider
Richard Paul Bryce0.24%121,662$866.23kInsider

1 of 3

PBYI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PBYI0.08%42.40%Net SellingNet Selling
PHAT0.09%41.16%Net SellingNet Selling
RZLT0.08%99.92%Net BuyingNet Selling
ALEC0.06%32.74%Net SellingNet Selling
IRD0.03%99.97%Net SellingNet Buying

Puma Biotechnology Stock Ownership FAQ

Who owns Puma Biotechnology?

Puma Biotechnology (NASDAQ: PBYI) is owned by 0.08% institutional shareholders, 42.40% Puma Biotechnology insiders, and 57.53% retail investors. Adage Capital Partners GP LLC is the largest individual Puma Biotechnology shareholder, owning 8.88M shares representing 17.17% of the company. Adage Capital Partners GP LLC's Puma Biotechnology shares are currently valued at $62.60M.

If you're new to stock investing, here's how to buy Puma Biotechnology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.